Jornay Pm
Payments companies reported to CMS as associated with Jornay Pm. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Jornay Pm, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Jornay Pm
These are the largest totals companies reported as associated with Jornay Pm. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Maitri Patel | Framingham, MA | Child & Adolescent Psychiatry | $173,839.69 |
| James Anderson | High Point, NC | Pediatrics | $145,600.31 |
| Floyd Sallee | Charleston, SC | Psychiatry | $120,725.33 |
| Corey Hebert | Gretna, LA | Pediatrics | $51,448.43 |
| Brandi Rudolph Bolling | Jasper, AL | Psychiatry | $47,245.80 |
| Ann Childress | Las Vegas, NV | Child & Adolescent Psychiatry | $44,411.61 |
| Kenneth Brown | Brentwood, NH | Psychiatry | $43,694.77 |
| Kenneth Pittman | Chattanooga, TN | Child & Adolescent Psychiatry | $42,133.85 |
| Birgit Amann | Troy, MI | Child & Adolescent Psychiatry | $41,169.22 |
| Carolyn Lentzsch-Parcells | Fort Worth, TX | Pediatrics | $38,882.31 |
Prescribed Jornay Pm?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.